Rasat Tablet 1mg (Rasagiline Mesylate)
Rasagiline Mesylate 1.56mg
Tablet · Prescription medication
Korea Prime Pharmaceutical Co., Ltd.
MFDS item code 202000007 · Approved 2020.01.02
This product's status changed to Expired on 2025.01.02. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of idiopathic Parkinson’s disease
In the treatment of idiopathic Parkinson's disease, dopamine agonists can be used alone initially, or in combination with dopamine agonists if necessary. Additionally, for patients with motor dyskinesia symptoms, which occur when the efficacy wanes, levodopa can be administered as an adjunct to control the symptoms. This helps to improve the patient's motor function and manage the symptoms effectively.
This drug is administered orally to adults once daily as monotherapy or adjunctive therapy. 1) Monotherapy or adjunctive therapy to a dopamine agonist: Administer 1 mg orally once daily. 2) Adjunctive therapy to levodopa: The recommended initial dose for patients taking levodopa is 0.5 mg once daily. If well tolerated and the clinical response is insufficient, the dose may be increased to 1 mg once daily. This drug may be taken with or without food.
This medication should not be used in patients with an allergy to any of its components. It should not be taken together with other MAO inhibitors, certain analgesics, cold medications, etc., as serious side effects may occur. It is safe not to administer to patients with moderate or severe liver dysfunction. While on this medication, various side effects such as headache, dizziness, depression, hallucinations, indigestion, skin rash, and arthralgia may occur; if any abnormal symptoms appear, immediate consultation with a healthcare professional is advised. In particular, sudden drowsiness or sleep attacks may occur during the use of this drug; caution is required when driving or operating dangerous machinery. Pregnant or nursing women should exercise caution when using this drug, and safety in children under 18 years has not been established. In case of overdose, severe side effects may occur, hence the prescribed dosage must be followed, and it should be stored out of reach of children.
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air and moisture; therefore, it is important to store it in a sealed container. Furthermore, to maintain the drug's effectiveness, it should be stored at a cool temperature between 1°C and 25°C.
White round tablets
30 tablets/box [(10 tablets/PTP x 3)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Rasagiline Mesylate 1.56mg
Tablet · Prescription medication
Korea Prime Pharmaceutical Co., Ltd.

Rasagiline Mesylate 1.56mg
Tablet · Prescription medication
Hana Lundbeck Co., Ltd.

Rasagiline Mesylate 0.78mg
Tablet · Prescription medication
Korea Lundbeck Co., Ltd.

Rasagiline Mesylate 1.56mg
Tablet · Prescription medication
Jongkundang Co., Ltd.

Rasagiline Mesylate 0.78mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Rasagiline Mesylate 1.56mg
Tablet · Prescription medication
Korea Pharma Co., Ltd.

Rasagiline Mesylate 1.56mg
Tablet · Prescription medication
Myungin Pharmaceutical Co., Ltd.

Rasagiline Mesylate 0.78mg
Tablet · Prescription medication
Myungin Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.